Advancing Drug Discovery Through AI-Powered Solutions
Eidogen-Sertanty is dedicated to improving healthspan, medicine, and general well-being through cutting-edge pharmaceutical research tools.
LEARN MORE
Our Products
Kinase Foundation ModelNew!
One model. 478 kinases. Sequence in, ranking out. Trained on the Kinase Knowledgebase, it reads the kinase’s amino-acid sequence itself — no structure, no docking, no binding-site definition — so a single model covers the whole panel instead of one model per target.
Give it a kinase sequence and two compounds and it says which binds more tightly: 78.5% correct on more than 3 million held-out compound pairs, and 90% when the two compounds differ by more than tenfold in potency. Accuracy varies by target, so it is reported kinase by kinase.
Explore the Kinase Foundation Model →Kinase Knowledgebase (KKB)
Currently the Kinase Knowledgebase Q2 2026 Release includes the following data:
- Journal articles and patents: 10,326
- Number of Biological Activity Data Points: 3,336,903
- Number of unique kinase molecules with annotated assay data: 509,691
- Number of all unique kinase molecules from patents and articles (with or without bio-activity data): 854,437
- Number of unique kinase targets with assay data: 579
- Number of annotated assay protocols: 105,916
- Machine-learning models built from this release’s SAR: activity classifiers across 392 kinase targets, median ROC-AUC 0.91 (0.95 for well-studied kinases) – view model performance report
To show what this depth of curation supports, we build machine-learning models from the KKB SAR and report how they perform: an activity classifier for each of 392 kinase targets and a potency regressor for 319 of them. The panel at left summarises classifier accuracy — ROC curves grouped by how much data each kinase has, the spread of ROC-AUC, and how accuracy rises with the depth of measured chemistry.
Accuracy is highest for compounds chemically related to what a target already has in KKB and declines for novel scaffolds, so every prediction is reported with a similarity score against the model’s own training set. Performance is also measured against published data absent from the knowledgebase.
Search the Kinase Knowledgebase →
Oncology Knowledgebase (OKB)
Currently the Oncology Knowledgebase Q2 2023 Release includes the following data:
- Journal articles and patents: 977
- Number of Biological Activity Data Points: 146,206
- Number of molecules from patents and articles: 66,198
- Number of unique oncology targets with assay data: 1,158
- Number of annotated assay protocols: 5,614
- Number of disease models: 137
Dataset Overlap AnalysisNew
How much of a dataset do you already have? Our toolkit answers that for any two SAR datasets — any target family — without either side revealing a structure. Each party encodes its own data locally into irreversible SHA-256 fingerprints; only fingerprints are compared, and only the overlap figure is shared.
How it works → Download the toolkit →
Target Informatics Platform (TIP™)
The Target Informatics Platform's content grows weekly with more than 200K high resolution protein structures, ~1.2M annotated co-complex sites, and an additional ~875K predicted sites. TIP contains more than 710K protein chains representing every major drug target family.
Learn More →














